Seismic Therapeutic Closes $121 Million Series B

Boston – December 4, 2023 – Cooley advised Seismic Therapeutic, a biotechnology company using machine learning to make a major shift in how immunology therapies are discovered and developed, on the close of its Series B financing at $121 million. Partners Michael Rohr and Marc Recht led the Cooley team advising Seismic.

The financing was led by new investor Bessemer Venture Partners, with participation from other new investors – Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels and GC&H – as well as existing investors Timothy A. Springer, Lightspeed Venture Partners, Polaris Partners, Boxer Capital, GV, Samsara BioCapital, and management and founders.

Proceeds from the financing will be used to advance Seismic’s two lead programs – a pan‑immunoglobulin (Ig) G protease sculpting (Sc) enzyme candidate (S-1117) and a PD-1 agonist:Fc gamma receptor IIb selective dual-cell bidirectional (DcB) antibody candidate (S-4321) – through phase 1 proof-of-mechanism trials, and enable the continued growth of its pipeline in the IgSc and DcB product areas beyond the lead programs. Seismic also will use the funding to further expand its proprietary machine learning-enabled IMPACT platform with the development and implementation of additional cutting-edge methods to enhance biologics drug discovery in immunology.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.